Seroconversion Is Misleading as a Test for HSV-2 Infection in Prophylactic Genital Herpes Vaccine Trials: Results of Vaccine Studies in Guinea Pigs
Seroconversion is defined as a four-fold or greater rise in antibody titers. This assay is used in human prophylactic vaccine trials to confirm HSV as the cause of genital lesions and detect subclinical latent infection. We evaluated the accuracy of seroconversion in detecting infection using a guin...
Saved in:
| Main Authors: | Valerie Bromberg, Lauren M. Hook, John M. Lubinski, Zauraiz Syeda, Kevin P. Egan, Gary H. Cohen, Sita Awasthi, Harvey M. Friedman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/6/773 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interest and Expectations for a Herpes Vaccine Among People Diagnosed with Genital HSV 1-2 Infection: Results from an Italian Survey
by: Lovel Lisac, et al.
Published: (2024-11-01) -
MODERN ASPECTS OF TREATMENT OF GENITAL HERPES INFECTION
by: I. O. Makarov, et al.
Published: (2016-05-01) -
Low IgG Seroconversion among Persons Vaccinated against Measles, Republic of Congo
by: Yanne Vanessa Thiécesse Mavoungou, et al.
Published: (2025-01-01) -
Seroprevalence of HSV-2 in multiple subgroups of infertile men with abnormal sperm parameters and those seeking sex selection: a case-control study
by: Mohamad Javad Mahmodi, et al.
Published: (2025-01-01) -
Syndemic Synergy of HPV, HIV, and HSV-2 for Oncogenic HPV Replication in Female Sex Workers
by: Jonathan Muwonga Tukisadila, et al.
Published: (2025-06-01)